C12Y 301/31001
Micrococcal nuclease
Official title: Micrococcal nuclease (3.1.31.1)
C12Y301/31001 (Micrococcal nuclease) appears on 11 US grants and 19 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 19
- Assignees
- 14
- Inventors
- 49
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 4 |
| 2021 | 0 | 2 |
| 2022 | 2 | 1 |
| 2023 | 1 | 4 |
| 2024 | 2 | 2 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Isolation and characterization of the nuclear proteome15 Apr 2025US 12,276,667 B2Altius Institute for Biomedical Sciences
- Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes1 Oct 2024US 12,104,199 B2EpiCypher, Inc.
- Compositions and methods for cellular processing20 Aug 2024US 12,065,688 B210x Genomics, Inc.
- Methods for microbial DNA analysis4 Apr 2023US 11,618,917 B2PathogenDx, Inc.
- Compositions, methods, and kits for one-step digestion of nucleic acid for analysis by liquid chromatography tandem mass spectrometry13 Sep 2022US 11,441,170 B2University of Cincinnati
- Methods, compositions, and kits for detecting spatial chromosomal interactions23 Jul 2026US 2026/0209833 A110x Genomics, Inc.
- Isolation and Characterization of the Nuclear Proteome3 Jul 2025US 2025/0216400 A1Altius Institute for Biomedical Sciences
- Inhibitors of the mtdh-snd1 protein complex for cancer therapy5 Dec 2024US 2024/0398767 A1The Trustees of Princeton University
- Compounds and methods for biofilm disruption and prevention21 Mar 2024US 2024/0091332 A1University of New Castle Upon Tyne
- Parapharmaceutical or pharmaceutical composition administrable to a living being, preferably a human being, comprising at least one enzyme for the treatment and/or prevention of bacterial infections involving biofilm formation7 Dec 2023US 2023/0390366 A1
Most cited
By later US patents
- Compositions and methods for cellular processing16US 12,065,688 B210x Genomics, Inc. · 2024
- Compounds and methods for biofilm disruption and prevention10US 9,675,736 B2University of Newcastle Upon Tyne · 2017
- Vector plasmid suited for souring agents, dairy souring agents in particular3US 4,977,088 AValio Meijerien Keskusosuusliike · 1990
- Compounds and methods for biofilm disruption and prevention2US 10,300,173 B2University of Newcastle Upon Tyne · 2019